Efficient inventory management is crucial for medtech companies to drive innovation and improve patient outcomes. Excessive inventory not only ties up capital but also increases warehousing costs and the risk of write-offs. By adopting advanced strategies, medtech organizations can transform their stock from a liability into an asset, freeing up cash for product development and acquisitions. This article explores operational and structural improvements that can significantly reduce inventory levels and enhance cash flow.
Medtech firms can achieve better inventory management by focusing on three key operational areas: demand forecasting, visibility into inventory, and specifying product mix requirements in contracts. Accurate demand planning at the SKU level is essential for maintaining healthy inventory levels. Many companies rely on broad forecasts, which can obscure significant errors at the SKU level. Leading firms leverage digital tools and AI to forecast more precisely, reducing both finished goods and raw material buildup.
Furthermore, comprehensive visibility into all available inventory, including products, components, and raw materials, is vital for effective management. Siloed data systems and earmarked inventory for preferred customers often lead to overordering and product accumulation. To address this, medtechs should prioritize detailed tracking across all storage locations. Strategic buffers should be consolidated in one central location to minimize costs. Additionally, internal manufacturing divisions need more specific incentives to produce the right mix of products, ensuring balanced production and avoiding shortages or surpluses.
Integrating inventory optimization into product development, consignment models, and supply chain design can have a profound impact on cash flow. Forward-thinking product development can prevent surplus inventory and high obsolescence rates. For example, standard surgical sets often include rarely used components, leading to unnecessary buildup. By designing more flexible sets, medtechs can reduce excess stock while maintaining necessary items.
Flexible consignment models tailored to specific business conditions are another critical improvement. Traditional "consign and overstock" models inflate inventory and increase obsolescence risks. Instead, medtechs can prioritize patient health with more efficient models based on customer needs and surgery types. Centralized holding of inventory for elective surgeries can reduce unnecessary buildup. Moreover, streamlining the supply chain by reducing nodes can optimize inventory value and maintain high service levels. Advanced planning systems, when properly implemented, can further enhance these efforts by coordinating various tasks such as forecasting and supplier collaboration. However, success depends on transforming old ways of working and ensuring data accuracy.